End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.22 CNY | -2.06% |
|
-4.53% | +2.42% |
Business Summary
Number of employees: 867
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
99.3
%
| 302 | 99.8 % | 384 | 99.3 % | +27.14% |
Pharmaceutical Intermediates and Raw Materials
0.7
%
| 1 | 0.2 % | 3 | 0.7 % | +342.17% |
Asset Licensing
0.0
%
| - | - | 0 | 0.0 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 302 | 100.0 % | 386 | 100.0 % | +27.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hui Ping Lu
FOU | Founder | 57 | 17/03/09 |
Ze Lin Sheng
CEO | Chief Executive Officer | 64 | 17/03/09 |
Gang Huang
DFI | Director of Finance/CFO | 53 | 31/12/18 |
Ji Sheng Wu
BRD | Director/Board Member | 59 | 30/06/16 |
Wei Hao Ma
IRC | Investor Relations Contact | 37 | 30/06/19 |
Qing Ping Gao
SEC | Corporate Secretary | 47 | 30/06/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bing Hui Zhang
BRD | Director/Board Member | 61 | - |
Ze Lin Sheng
CEO | Chief Executive Officer | 64 | 17/03/09 |
Hui Ping Lu
FOU | Founder | 57 | 17/03/09 |
Ji Sheng Wu
BRD | Director/Board Member | 59 | 30/06/16 |
Ruyi He
BRD | Director/Board Member | 63 | 31/01/19 |
Bin Hua Lü
BRD | Director/Board Member | - | 18/05/22 |
De Yu Li
BRD | Director/Board Member | - | 18/05/22 |
Yuan Qi Ren
BRD | Director/Board Member | - | 18/05/22 |
Bi Hui Yi
CHM | Chairman | - | 18/05/22 |
Meng Heng Zhang
BRD | Director/Board Member | 48 | 14/12/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 264,708,186 | 141,104,405 ( 53.31 %) | 0 | 53.31 % |
Company contact information
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
No. 209, Chenfeng Road Yushan Town
215300, Kunshan
+
http://www.zelgen.com![address Suzhou Zelgen Biopharmaceuticals Co.,Ltd.(688266)](https://cdn.zonebourse.com/static/address/101394188.png)
Sector
Sales per Business
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.42% | 2.02B | |
+55.69% | 819B | |
-7.01% | 351B | |
+17.04% | 329B | |
+9.61% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.19% | 168B | |
-2.88% | 158B |
- Stock Market
- Equities
- 688266 Stock
- Company Suzhou Zelgen Biopharmaceuticals Co.,Ltd.